Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.
Vanbockstael J, Coquan E, Gouerant S, Allouache D, Faveyrial A, Noal S, Delcambre C, Galais MP, Héron JF, Lefebvre AC, Sevin E, Hrab I, Polycarpe F, André M, Kaluzinski L, Gervais R, Gunzer K, Vié B, Saucier G, Lemenand N, Grellard JM, Clarisse B, Dugué AE, Joly F. Vanbockstael J, et al. Among authors: gervais r. Support Care Cancer. 2016 Mar;24(3):1131-8. doi: 10.1007/s00520-015-2882-7. Epub 2015 Aug 14. Support Care Cancer. 2016. PMID: 26268784
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting.
Sassier M, Dugué AE, Clarisse B, Lesueur P, Avrillon V, Bizieux-Thaminy A, Auliac JB, Kaluzinski L, Tillon J, Robinet G, Le Caer H, Monnet I, Madroszyk A, Boza G, Falchero L, Fournel P, Egenod T, Toffart AC, Leiber N, Do P, Gervais R. Sassier M, et al. Among authors: gervais r. Lung Cancer. 2015 Aug;89(2):161-6. doi: 10.1016/j.lungcan.2015.05.005. Epub 2015 May 15. Lung Cancer. 2015. PMID: 26037036
Chemotherapy (platinum and pemetrexed) in combination with erlotinib in non-small cell lung cancer induces major gastrointestinal toxicity: two case reports from the FLARE/GFPC 03-2013 study.
Sassier M, Peyro-Saint-Paul L, Clarisse B, Leconte A, Coquerel A, Alexandre J, Fedrizzi S, Leroy-Terquem E, Madroszyk A, Gervais R. Sassier M, et al. Among authors: gervais r. J Clin Pharm Ther. 2016 Aug;41(4):447-448. doi: 10.1111/jcpt.12406. Epub 2016 Jun 15. J Clin Pharm Ther. 2016. PMID: 27306517
Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Dupont B, Mariotte D, Dugué AE, Clarisse B, Grellard JM, Babin E, Chauffert B, Dakpé S, Moldovan C, Bouhier-Leporrier K, Reimund JM, Di Fiore F, Zanetta S, Mailliez A, Do P, Peytier A, Galais MP, Florescu C, Schott R, Le Mauff B, Gervais R. Dupont B, et al. Among authors: gervais r. Br J Clin Pharmacol. 2017 Mar;83(3):623-631. doi: 10.1111/bcp.13140. Epub 2016 Oct 24. Br J Clin Pharmacol. 2017. PMID: 27662818 Free PMC article.
Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.
Rambeau A, Gervais R, De Raucourt D, Babin E, Dugué AE, Florescu C, Blanchard D, Gery B. Rambeau A, et al. Among authors: gervais r. Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2883-2889. doi: 10.1007/s00405-017-4550-7. Epub 2017 Apr 5. Eur Arch Otorhinolaryngol. 2017. PMID: 28382396
[Malignant mesothelioma and constitutional BAP1 gene mutations].
Neviere Z, Berthet P, Polycarpe F, Dubos-Arvis C, Dô P, Gervais R. Neviere Z, et al. Among authors: gervais r. Rev Mal Respir. 2019 Feb;36(2):241-248. doi: 10.1016/j.rmr.2017.11.014. Epub 2019 Jan 24. Rev Mal Respir. 2019. PMID: 30686559 Review. French.
323 results